Mike Ross
InvestorPartner at SV Health Investors · Board director at Xilio Therapeutics · Board director at Avitide · Board director at Ophthotech
San Mateo, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Mike
143 people in our graph share verified history with Mike — schools, employers, funds. One of them is your warm intro.
About
Mike Ross joined SV Health Investors as a Venture Partner in 2001 and became Managing Partner in 2002, where he leads biotech investments and activities in the US and co-leads the firm's biotech franchise. Before SV, he spent 13 years at Genentech as its tenth employee, holding roles including Vice President of Development and Vice President of Medicinal and Biomolecular Chemistry, and was Founding CEO of Arris Pharmaceutical. He holds an AB from Dartmouth College, a PhD in Chemistry from Caltech, and completed an NIH Post-Doctoral Fellowship in Molecular Biology at Harvard.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Xilio Therapeutics
Intro paths
In turn, Mike can intro founders to Xilio Therapeutics's investors below.
Xilio Therapeutics's investors · 16
Co-founders at Xilio Therapeutics
Board director at Avitide
Intro paths
In turn, Mike can intro founders to Avitide's investors below.
Avitide's investors · 7
Co-founders at Avitide
Board director at Ophthotech
Intro paths
In turn, Mike can intro founders to Ophthotech's investors below.
Ophthotech's investors · 4
Co-founders at Ophthotech
Experience
- SV Health InvestorsSenior Partnercurrent2001 — presentBoston, Massachusetts, United States
- MetaXenCEO1993 — 1996
- Arris PharmaceuticalCEO1990 — 1993
- GenentechVP Medicinal and Biomolecular Chemistry1987 — 1990
- GenentechVP Development1981 — 1987
- GenentechDirector Protein Chemistry1979 — 1981San Francisco Bay Area
- GenentechSr Scientist1978 — 1979San Francisco Bay Area
Skills & more
From Mike's professional profile.
Investments
Investor
ArchemixArsanisAvitideEyebiotechTherini BioThesan PharmaceuticalsXilio Therapeutics
Per curated public sources.
Colleagues at SV Health Investors
Frequently asked questions
- Who is Mike Ross?
- Mike Ross joined SV Health Investors as a Venture Partner in 2001 and became Managing Partner in 2002, where he leads biotech investments and activities in the US and co-leads the firm's biotech franchise. Before SV, he spent 13 years at Genentech as its tenth employee, holding roles including Vice President of Development and Vice President of Medicinal and Biomolecular Chemistry, and was Founding CEO of Arris Pharmaceutical. He holds an AB from Dartmouth College, a PhD in Chemistry from Caltech, and completed an NIH Post-Doctoral Fellowship in Molecular Biology at Harvard.
- Where does Mike Ross work?
- Mike Ross is Partner at SV Health Investors and Board director at Xilio Therapeutics and Board director at Avitide and Board director at Ophthotech.
- What does Mike Ross invest in?
- Mike Ross invests in Biotech.
- What check size does Mike Ross write?
- Mike Ross typically writes checks of $100K – $5M.
- What companies has Mike Ross invested in?
- Investments tracked here include Archemix, Arsanis, Avitide, Eyebiotech, Therini Bio, Thesan Pharmaceuticals, Xilio Therapeutics.
- Where did Mike Ross go to school?
- Mike Ross studied at Dartmouth College (AB, Chemistry); Harvard University (postdoc, Molecular Biology); Caltech (Doctor of Philosophy - PhD, Biophysics).
Same school
Also attended Dartmouth College660
+ 654 more
Also attended Harvard University2,000
+ 1,994 more
Also attended Caltech275
+ 269 more
Shared employers
Also worked at Genentech247
+ 241 more